The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cells
- DOI
- 10.1111/bph.70528
- Published
- 2026-06-30
- Container
- British Journal of Pharmacology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bph.70528,
title = {The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cells},
author = {Alina Zorn and John Daniel Pediani and Madihah Hussain and Jiayue Ling and Elaine Brown and Igor Belka and Eduardo Torres and Cathy Swindlehurst and Kyle Chan and David Stirling and George S. Baillie and Yuan Yan Sin},
year = {2026},
journal = {British Journal of Pharmacology},
doi = {10.1111/bph.70528},
url = {https://doi.org/10.1111/bph.70528}
}RIS
TY - JOUR TI - The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cells AU - Alina Zorn AU - John Daniel Pediani AU - Madihah Hussain AU - Jiayue Ling AU - Elaine Brown AU - Igor Belka AU - Eduardo Torres AU - Cathy Swindlehurst AU - Kyle Chan AU - David Stirling AU - George S. Baillie AU - Yuan Yan Sin PY - 2026 JO - British Journal of Pharmacology DO - 10.1111/bph.70528 UR - https://doi.org/10.1111/bph.70528 ER -
APA
Zorn, A., Pediani, J. D., Hussain, M., Ling, J., Brown, E., Belka, I., Torres, E., Swindlehurst, C., Chan, K., Stirling, D., Baillie, G. S., & Sin, Y. Y. (2026). The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cells. British Journal of Pharmacology. https://doi.org/10.1111/bph.70528
Source records
- crossref · retrieved 2026-09-25T05:32:54.976Z